Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04646434 · ClinicalTrials.gov registry record · NA

Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical Prostatectomy

A NA study of Prostate Carcinoma, sponsored by Roswell Park Cancer Institute.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT04646434 is a NA study of Prostate Carcinoma that is actively recruiting participants, run by Roswell Park Cancer Institute. The registered enrollment target is 100 participants, below the 1,500-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04646434, a NA study of Prostate Carcinoma, is actively recruiting participants, sponsored by Roswell Park Cancer Institute.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This trial investigates brain and pelvic floor muscle activity in patients undergoing robot-assisted radical prostatectomy. This trial may help identify the brain waves that are associated with muscles involved in giving patients control over the bladder.

Conditions Studied

Interventions

  • OTHER Questionnaire Administration
  • PROCEDURE Electroencephalography
  • PROCEDURE Electromyography
  • PROCEDURE Urodynamics (UDS)

Study Locations (1)

New York

  • Roswell Park Cancer Institute - Buffalo

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-07-13
Est. Completion 2029-07-13
Phase NA

Sponsor

Roswell Park Cancer Institute

365 total trials

What the Registry Record Tells You About NCT04646434

The ClinicalTrials.gov registry entry for NCT04646434 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,500-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (93% lower). The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.

NCT04646434 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04646434 about?

NCT04646434 is a clinical study titled "Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical Prostatectomy". This trial investigates brain and pelvic floor muscle activity in patients undergoing robot-assisted radical prostatectomy. This trial may help identify the brain waves that are associated with muscles involved in giving patients control over the bladder.

What is the current status of trial NCT04646434?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-07-13. Estimated completion is 2029-07-13.

What conditions does trial NCT04646434 study?

This clinical trial studies the following conditions: Prostate Carcinoma.

What interventions are being tested in trial NCT04646434?

The interventions under investigation include: Questionnaire Administration (OTHER), Electroencephalography (PROCEDURE), Electromyography (PROCEDURE), Urodynamics (UDS) (PROCEDURE).

Who is sponsoring clinical trial NCT04646434?

This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04646434 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.